Key result
The renin-angiotensin system is associated with the pathogenesis of H. pylori-related gastric carcinogenesis, suggesting RAS inhibitors may provide tools for preventing this disease.
Why the study?
Do RAS inhibitors prevent H. pylori-related gastric carcinogenesis?
Do RAS inhibitors prevent H. pylori-related gastric carcinogenesis?
The renin-angiotensin system may play a key role in H. pylori-related gastric carcinogenesis, highlighting a potential novel preventive application for RAS inhibitors.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for RAS inhibitor prevention of H. pylori gastric cancer; leaves open any clinical role pending trials.
Sugimoto et al. (2011) conducted a review in Gastric cancer. RAS inhibitors was evaluated. The renin-angiotensin system is associated with the pathogenesis of H. pylori-related gastric carcinogenesis, suggesting RAS inhibitors may provide tools for preventing this disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: